Source document

False Claims Act Settlements and Judgments Exceed $2.68 Billion in Fiscal Year 2023

U.S. Department of Justice, Office of Public Affairs · Government · 22 Feb 2024 · United States

Has everything in it been taken?

CompleteReviewed 10 Oct 2026

Reviewed. Everything in it that belongs in the tables has been taken.

What the document holds

DOJ press release (22 Feb 2024) on FY2023 FCA recoveries: exceeding $2.68 billion; record 543 settlements and judgments; more than $75 billion since 1986; health care over $1.8 billion; relator typically 15-30%; 712 qui tam suits ("more than 13 new cases every week", average, not recorded); qui tam recoveries exceeding $2.3 billion; over $349 million to whistleblowers; PPP about 270 matters and over $48.3 million; laboratory/MSO kickback investigation: over $2.6 million from five entities and ten individuals in FY2023, 43 physicians and over $46 million to date; Kabbage proofs of claim (losses over $60 million alleged, a claim, not a recovery, not recorded). Whistleblower case: Rite Aid (complaint in intervention in a whistleblower suit). Named matters not linked to a qui tam suit in this release (not cases): Cigna $172 million (its intervention appears in the FY2022 release), Martin's Point $22.5 million, continuing Medicare Advantage suits, Cornerstone $21.6 million, Smart Pharmacy at least $7.4 million, Saratoga $7.1 million, Endo proof of claim, Modern Vascular suit, Cardiac Imaging $85.5 million, Carter Healthcare $22.9 million, ModMed $45.4 million, NextGen $31.2 million, Borgfeld $325,000, Drs. Shelton and Boedefeld $396,360, CenCal and providers $95.5 million, BioTelemetry nearly $45 million, Lincare $29.0 million, Advanced Bionics more than $11.0 million, Booz Allen $377 million, L3 $21.8 million, Boeing $8.1 million, Victory Automotive more than $9 million, Coyne PR $2.24 million, Seasholtz more than $600,000, Britton-Harr suit, Jelly Bean $293,771, Verizon over $4 million, GCI $40 million, International Vitamins $22.8 million, Yale/Dr. Krystal $1.5 million, Aronowitz $23.9 million, HX5 about $7.8 million, Dr. Chung $6.6 million. Two sidebar teasers of other DOJ releases (Nassenstein, Hilcorp) at the end of the page are not part of this release. Already in the data: 6 observations. Added: 2 rules, 6 observations, 1 case. Decision 10 pass (2026-10-10): every named settlement, judgment and newly announced government suit not already in cases.csv added as a case with whistleblower_link=not_stated (the document does not tie it to a whistleblower): 34 cases (30 settlements, 4 pending government suits or claims). Amounts as printed (lower/upper bounds and global vs civil parts explained in notes); individuals only where named by the agency as parties. Not recorded as cases: about 270 PPP matters (over $48.3 million) and 'settlements with 43 physicians and recoveries of over $46 million' (unnamed aggregates), and repeat mentions of continuing litigation against UnitedHealth, Independent Health, Elevance and Kaiser. Sidebar teasers (Nassenstein, Hilcorp) are other releases.

What it supports

49 rows on this site come from this document. Each one opens with the page and the exact words.

12 numbers35 cases2 rules

Other documents give different figures in 5 cases involving this one. Both are kept.

Numbers (12)

Cases and awards (35)

About the document

What it covers Annual FCA results for FY2023: total settlements and judgments, qui tam suits filed, recoveries in qui tam suits, relator awards (most years), health care share.

Notes Copy in raw/ is the Wayback Machine capture (archive_url); justice.gov served a bot-check page to scripted requests during this pass, which was not bypassed.

Source id usa-doj-fca-pr-fy2023 · accessed 3 Oct 2026